1.
|
Phase: Phase IV Type: Diagnostic, Treatment Status: Completed Age: 18 to 63 Sponsor: Other Protocol IDs: 3068A1-400, NCT00418236
|
|
2.
|
Phase: Phase III Type: Prevention Status: Completed Age: 35 and over Sponsor: NCI, Other Protocol IDs: NSABP P-2, CDR0000067081, NCT00003906
|
|
3.
|
Phase: Phase III Type: Natural history/Epidemiology, Supportive care Status: Completed Age: 65 and over Sponsor: Other Protocol IDs: IA0132, 1R13AG020218-01, N01-AG-1-2106, NCT00687102
|
|
4.
|
Phase: Phase II Type: Prevention Status: Completed Age: 23 to 47 Sponsor: NCI Protocol IDs: NCI-98-C-0123, MB-402, NCT00019500
|
|
5.
|
Phase: Phase II Type: Prevention, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-99017, NCI-G99-1662, NCT00004247
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: NU 98G1, NCI-G00-1710, NCT00004915
|
|
7.
|
Phase: No phase specified Type: Prevention Status: Completed Age: 30 to 45 Sponsor: Other Protocol IDs: NCRI-IBIS-RAZOR, EU-20053, UKCCCR-IBIS-RAZOR, ISRCTN17775670, NCT00031850
|
|
8.
|
Phase: No phase specified Type: Supportive care Status: Completed Age: Any age Sponsor: NCI, Other Protocol IDs: CDR0000069229, OHSU-6312, NCI-H02-0086, NCT00031811
|
|
9.
|
Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: MC0851, NCI-2009-01700, 07-008912, NCT01050842
|